An ulcerated lesion that measured approximately 2 cm in diameter had developed on an 80-year-old woman's scalp. The lesion featured a dark eschar that covered a slightly elevated, erythematous border. According to the patient's husband, a different lesion had been at the site 2 weeks earlier. He described the original as a "ball" that ulcerated, had no drainage, and formed a scab.
An ulcerated lesion that measured approximately 2 cm in diameter had developed on an 80-year-old woman's scalp. The lesion featured a dark eschar that covered a slightly elevated, erythematous border. According to the patient's husband, a different lesion had been at the site 2 weeks earlier. He described the original as a "ball" that ulcerated, had no drainage, and formed a scab. Another practitioner prescribed oral and topical antibiotics and performed an incisional biopsy that revealed mycosis fungoides, a cutaneous T-cell lymphoma. The lesion ulcerated, flattened, formed an eschar, and regressed. The patient's history included a mastectomy and postoperative radiation therapy for breast cancer 6 years earlier. At age 79 years, she had a severe, constant, and progressive sore throat with bilateral exudative tonsillitis and bilateral cervical adenopathy; a tonsillectomy and excisional biopsy of a right jugular lymph node were performed. Pathologic examination of the tissue was confounding; the findings suggested lymphoma and an atypical mycobacterial infection. Clarithromycin was given for several months; the condition improved. Large-cell anaplastic lymphoma is a distinct variant of lymphoma that is usually of T-cell lineage. The 3 clinical variants of this type of tumor are:
Cutaneous lesions are usually solitary or localized. Relapses and remissions are frequent. Radiation therapy may be useful for persistent lesions.
Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD
June 11th 2025RAD 2025. Lebrikizumab improved skin clearance, itch, and pigmentation in patients with skin of color and atopic dermatitis, with strong safety data through 24 weeks, according to late-breaking data.